Q4 2025 Earnings Call November 10, 2025 9:00 AM ESTCompany ParticipantsJon KatholDonnie King - President, CEO & ...
Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...
Ericsson (NASDAQ: ERIC) today announces that Moti Gyamlani will step down from his role as Senior Vice President and Head of Group Function Global Operations as of January 12, 2026, and remain at ...
Operations: During the third quarter of 2025, we produced approximately 17 million gallons of low-carbon ethanol, 46 thousand tons of protein and corn oil co-products, 42 thousand tons of sequestered ...
Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2025.